NEW YORK (GenomeWeb News) – AstraZeneca announced today announced a two-year collaboration with the University of Cambridge and Cancer Research UK on three preclinical and clinical oncology projects, including one focused on gaining a better understanding of the genetic makeup of a patient's cancer through their tumor DNA.

Overall, the collaboration aims to move cancer research forward by studying tumor mutations and new investigational therapies in prostate, pancreatic, and possibly other cancers.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.